NCT06634992 Observatory of the Lille Paediatric Allergy Unit
| NCT ID | NCT06634992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lille Catholic University |
| Condition | Child Allergy |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2022-01-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to set up a paediatric observatory within the allergology department of The saint Vincent Hospital, Lille. The study aims to: • Collect exhaustive prospective data from patients eligible for oral immunotherapy. This prospective observatory will enable statistical analyses to be carried out on common food allergens such as hazelnut, cashew nut, pistachio and others.
Eligibility Criteria
Inclusion criteria: * patient under 15 years and 9 months, * positive diagnosis of food allergy (positive food challenge test or "highly probable allergy", defined by a convincing history, a positive prick test and IgE \> 0.35 kUA/L), * eligible for oral food challenge * accepting the following allergens : hazelnut, walnut, pistachio, cashew, peanut, cow's milk, wheat, egg, sesame, celery, fenugreek, pea, lentils or others Exclusion criteria: * Opposition * Already received oral challenge for the same allergen.
Contact & Investigator
Tomas MORALY
PRINCIPAL INVESTIGATOR
Groupement des Hôpitaux de l'Institut Catholique de Lille
Frequently Asked Questions
Who can join the NCT06634992 clinical trial?
This trial is open to participants of all sexes, up to 16 Years, studying Child Allergy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06634992 currently recruiting?
Yes, NCT06634992 is actively recruiting participants. Contact the research team at tristram.domitille@ghicl.net for enrollment information.
Where is the NCT06634992 trial being conducted?
This trial is being conducted at Lille, France.
Who is sponsoring the NCT06634992 clinical trial?
NCT06634992 is sponsored by Lille Catholic University. The principal investigator is Tomas MORALY at Groupement des Hôpitaux de l'Institut Catholique de Lille. The trial plans to enroll 1,000 participants.